Phosphodiesterase Type-5 Inhibitor Use in Type 2 Diabetes Is Associated With a Reduction in All Cause Mortality
Artery Research
doi 10.1016/j.artres.2014.09.162
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2014
Authors
Publisher
Atlantis Press